Showing results (111-120 of 530) with videos related to
Sort By:
Pageof 53
Gastroenterology|March 1, 2011
Microsomal prostaglandin E synthase-1 inhibits PTEN and promotes experimental cholangiocarcinogenesis and tumor progressionDongdong Lu, Chang Han, Tong WuThe Journal of Biological Chemistry|September 13, 2006
A novel positive feedback loop between peroxisome proliferator-activated receptor-delta and prostaglandin E2 signaling pathways for human cholangiocarcinoma cell growthLihong Xu, Chang Han, Tong WuJournal of Breast Cancer|January 5, 2019
New Insights into the Role of Endoplasmic Reticulum Stress in Breast Cancer MetastasisChang-Chang Han, Fu-Sheng WanTrends in Pharmacological Sciences|December 13, 2021
Will ETA-antibody arouse new interest in cancer therapeutics?Ji-Young Park, Chang-Han LeeGastroenterology|April 10, 2012
MicroRNA-26a promotes cholangiocarcinoma growth by activating β-cateninJinqiang Zhang, Chang Han, Tong WuCarcinogenesis|August 3, 2015
MiR-17-92 cluster promotes hepatocarcinogenesisHanqing Zhu, Chang Han, Tong WuThe Journal of Biological Chemistry|May 21, 2013
15-hydroxyprostaglandin dehydrogenase-derived 15-keto-prostaglandin E2 inhibits cholangiocarcinoma cell growth through interaction with peroxisome proliferator-activated receptor-γ, SMAD2/3, and TAP63 proteinsDongdong Lu, Chang Han, Tong WuMedical Science Monitor Basic Research|October 23, 2013
Decipher β2-microglobulin: gain- or loss-of-function (a mini-review)Shean-Jaw Chiou, Chang-Han ChenGuang Pu Xue Yu Guang Pu Fen Xi = Guang Pu|September 25, 2013
[Research on hyperspectral remote sensing inversion of barrier factors in saline-alkaline land use]Ji-Chang Han, Xiao-Ming LiBiotechnology and Bioprocess Engineering : BBE|July 5, 2021
Development of Therapeutic Antibodies and Modulating the Characteristics of Therapeutic Antibodies to Maximize the Therapeutic EfficacySeung Hyun Kang, Chang-Han LeePageof 53